Histopathological Insights into Neurological Disorders

Martins Garcia^*
*Correspondence: Martins Garcia, Department of Phonoaudiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21044-020, Brazil, Email:

Introduction

Histopathology is a crucial tool in understanding neurological disorders. By studying tissue samples under the microscope, histopathologists can provide valuable insights into the underlying mechanisms of diseases affecting the nervous system. Neurological disorders, ranging from neurodegenerative diseases like Alzheimer's and Parkinson's to stroke, epilepsy, and multiple sclerosis, can all be explored in depth through histopathological examination. The microscopic alterations in brain tissue provide essential information for diagnosis, prognosis, and the development of targeted therapies. These changes often reflect the complex interplay between genetic, environmental, and molecular factors, and the analysis of histopathological specimens helps to uncover the pathophysiology behind these disorders.

In neurodegenerative diseases such as Alzheimer's Disease (AD), histopathological findings are crucial for confirming diagnosis and understanding the progressive nature of the disorder. Alzheimer's is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. Amyloid plaques are abnormal clusters of protein that form outside neurons, while neurofibrillary tangles are twisted fibers of tau protein found inside neurons. The presence of these structures is one of the hallmarks of Alzheimer's disease, and their distribution correlates with the cognitive decline experienced by patients. Histopathological examination of brain tissue, often obtained post-mortem, allows pathologists to visualize these plaques and tangles, which are not always detectable in clinical imaging. Furthermore, histological staining techniques, such as Congo red staining for amyloid plaques and silver staining for tau tangles, allow for precise identification of these pathological features [1].

Description

Parkinson’s disease (PD), another neurodegenerative disorder, is characterized by the loss of dopaminergic neurons in the substantia nigra, a region of the brain involved in motor control. Histopathological examination reveals the presence of Lewy bodies, abnormal aggregates of alpha-synuclein protein, in the affected neurons. Lewy bodies are considered a hallmark of Parkinson’s disease and other synucleinopathies, including dementia with Lewy bodies and multiple system atrophy [2]. The accumulation of alpha-synuclein within neurons disrupts their normal function and leads to neurodegeneration. Histopathological analysis of brain tissue from patients with PD shows the gradual loss of pigmented neurons in the substantia nigra, often accompanied by gliosis (the proliferation of glial cells in response to injury) and neuronal loss in other regions such as the striatum [3].

Multiple sclerosis (MS) is an autoimmune disorder characterized by demyelination in the Central Nervous System (CNS), leading to neurological disability. The histopathological features of MS are distinct and provide valuable diagnostic clues. In MS, there is loss of myelin, the protective sheath surrounding nerve fibers, along with the presence of inflammatory cells, primarily T lymphocytes, macrophages, and B cells, which infiltrate the affected areas. The demyelinated plaques are often observed in the white matter of the brain and spinal cord, with varying degrees of tissue damage. The plaques are typically surrounded by reactive astrocytes, which attempt to repair the damaged tissue [4]. Histological analysis of these plaques can reveal areas of active demyelination, where oligodendrocytes (the cells responsible for myelin production) are being destroyed, and areas of remyelination, where new myelin sheaths are being formed. Staining techniques such as luxol fast blue can highlight areas of demyelination, and immunohistochemistry can be used to detect the presence of specific immune cell populations involved in the inflammatory response.

Stroke, which involves the interruption of blood supply to the brain, leading to tissue injury and death, also has characteristic histopathological features. The extent of damage depends on the type of stroke, whether ischemic or hemorrhagic. In ischemic stroke, blood flow is blocked, leading to oxygen and nutrient deprivation in the affected brain regions. Histopathological, ischemic stroke results in neuronal necrosis, microglial activation, and astrocyte proliferation in the damaged area. The histopathological changes are often most prominent in the core of the infarction, where cell death occurs, and in the surrounding penumbra, where there is reversible damage. In hemorrhagic stroke, blood vessels rupture, leading to bleeding within the brain. Histopathological examination reveals hematoma formation, along with the presence of red blood cells, neutrophils, and macrophages involved in clearing the blood and tissue debris. Both types of stroke show evidence of neuronal injury, including the presence of pyknotic nuclei, cell swelling, and loss of cellular integrity.

Epilepsy, a neurological disorder characterized by recurrent seizures, can also be studied through histopathology. Although the primary cause of epilepsy may vary, some common histopathological features are observed, particularly in cases of Temporal Lobe Epilepsy (TLE), the most common form of focal epilepsy. In TLE, there is often hippocampal sclerosis, characterized by neuronal loss, gliosis, and the formation of aberrant synapses. The loss of neurons, particularly in the CA1 region of the hippocampus, is associated with abnormal reorganization of neuronal circuits, which can contribute to the hyperexcitability seen in epileptic seizures. Histopathological analysis of brain tissue from epilepsy patients often reveals the presence of ectopic neurons, as well as abnormalities in the synaptic structure, which further support the idea that structural changes in the brain can lead to the development of seizures. Immunohistochemical techniques can help identify the specific types of cells involved in these changes and provide insight into the molecular mechanisms underlying epilepsy [5].

In addition to these specific disorders, histopathology can be applied to a broad range of other neurological conditions. For example, in prion diseases such as Creutzfeldt-Jakob Disease (CJD), histopathological examination reveals spongiform changes in the brain, including vacuolization and neuronal loss. The presence of abnormal prion proteins can be detected by immunohistochemistry, which helps in the diagnosis of these rare but rapidly progressing conditions. Similarly, in neuroinfections, such as viral encephalitis, histopathological analysis may show signs of inflammation, including the presence of lymphocytes and microglial activation, along with evidence of neuronal death. In addition, histopathological studies of brain tumors, such as gliomas, can provide critical information about the tumor’s grade, cell origin, and the presence of markers that guide treatment decisions.

Conclusion

In conclusion, histopathology offers a window into the intricate changes occurring in the brain and nervous system in response to neurological disorders. Through the examination of tissue samples, pathologists can identify the hallmark features of various diseases, uncover the underlying mechanisms of neurodegeneration and injury, and contribute to the development of targeted treatments. As our understanding of the molecular and cellular basis of neurological disorders continues to grow, histopathological analysis will remain an essential tool in both the diagnosis and treatment of these complex diseases. By complementing other diagnostic and therapeutic approaches, histopathology plays a pivotal role in advancing our knowledge of the brain and improving the lives of those affected by neurological conditions.

Acknowledgment

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Rasmussen, Sonja A., Denise J. Jamieson, Margaret A. Honein and Lyle R. Petersen. "Zika virus and birth defects-reviewing the evidence for causality." N Engl J Med 374 (2016): 1981-1987.

   Google Scholar, Crossref, Indexed at

2. Brasil, Patrícia, Jose P. Pereira Jr, M. Elisabeth Moreira and Rita M. Ribeiro Nogueira, et al, Mayumi Wakimoto, Renata S. Rabello et al. "Zika virus infection in pregnant women in Rio de Janeiro." N Engl J Med 375 (2016): 2321-2334.

   Google Scholar, Crossref, Indexed at

3. Andrade, Gleice Kelli Santana de, Elen Ferraz Teston, Sonia Silva Marcon and Bianca Cristina Ciccone Giacon-Arruda, et al. "Congenital Zika virus syndrome: Care in light of the Brazilian Unified Health System principles." Rev Bras Enferm 75 (2021): e20210146.

   Google Scholar, Crossref, Indexed at

4. Faiçal, Adriana Virginia, Juliana Cabral de Oliveira, João Vitor Vieira Oliveira and Breno Lima de Almeida, et al. "Neurodevelopmental delay in normocephalic children with in utero exposure to Zika virus." BMJ Paediatr Open 3 (2019): e000486.

   Google Scholar, Crossref, Indexed at

5. Fandiño-Cárdenas, Marcela, Alvaro J. Idrovo, Roman Velandia and Jessica Molina-Franky, et al. "Zika virus infection during pregnancy and sensorineural hearing loss among children at 3 and 24 months post-partum." J Trop Pediatr 65 (2019): 328-335.

   Google Scholar, Crossref, Indexed at